Lupus Erythematosus

Long-term open-label continuation study of the safety and efficacy of belimumab for up to 7 years in patients with systemic lupus erythematosus from Japan and South Korea
Yoshiya Tanaka, Sang-Cheol Bae, Damon Bass, Paula Curtis, Myron Chu, Kathleen DeRose, Beulah Ji, Regina Kurrasch, Jenny Lowe, Paige Meizlik, David A Roth

RMD Open Jul 2021, 7 (2) e001629; DOI: 10.1136/rmdopen-2021-001629
Validation of a machine learning approach to estimate Systemic Lupus Erythematosus Disease Activity Index score categories and application in a real-world dataset
Pedro Alves, Jigar Bandaria, Michelle B Leavy, Benjamin Gliklich, Costas Boussios, Zhaohui Su, Gary Curhan

RMD Open May 2021, 7 (2) e001586; DOI: 10.1136/rmdopen-2021-001586
White matter hyperintensities associate with cognitive slowing in patients with systemic lupus erythematosus and neuropsychiatric symptoms
Rory Caitlin Monahan, Francesca Inglese, Huub Middelkoop, Mark van Buchem, Tom WJ Huizinga, Margreet Kloppenburg, Itamar Ronen, Gerda M Steup-Beekman, Jeroen de Bresser

RMD Open Jul 2021, 7 (2) e001650; DOI: 10.1136/rmdopen-2021-001650
Suitability for e-health of non-pharmacological interventions in connective tissue diseases: scoping review with a descriptive analysis
Valentin Ritschl, Ricardo J O Ferreira, Eduardo José Ferreira Santos, Rúben Fernandes, Essi Juutila, Erika Mosor, Paulo Santos-Costa, Kim Fligelstone, Linda Schraven, Georg Stummvoll, Maria Salvador, Janet L Poole, Cornelia van den Ende, Carina Boström, Tanja A Stamm

RMD Open Jul 2021, 7 (2) e001710; DOI: 10.1136/rmdopen-2021-001710
Neutrophil extracellular traps (NET): not only antimicrobial but also modulators of innate and adaptive immunities in inflammatory autoimmune diseases
Dyhia Melbouci, Ahmad Haidar Ahmad, Patrice Decker

RMD Open Aug 2023, 9 (3) e003104; DOI: 10.1136/rmdopen-2023-003104
Controversies over hydroxychloroquine in the prevention of SARS-CoV-2 infection put rheumatologists on the frontline
Serena Bugatti, Ludovico De Stefano, Francesca Bobbio-Pallavicini, Carlomaurizio Montecucco

RMD Open Oct 2020, 6 (3) e001323; DOI: 10.1136/rmdopen-2020-001323
Points to consider for the treatment of immune-mediated inflammatory diseases with Janus kinase inhibitors: a systematic literature research
Andreas Kerschbaumer, Josef S Smolen, Peter Nash, Thomas Doerner, Maxime Dougados, Roy Fleischmann, Klaus Geissler, Iain B McInnes, Tsutomu Takeuchi, Michael Trauner, Kevin Winthrop, Maarten de Wit, Wolf-Henning Boehncke, Louise Falzon, Desirée van der Heijde

RMD Open Nov 2020, 6 (3) e001374; DOI: 10.1136/rmdopen-2020-001374
Predictors of renal damage in systemic lupus erythematous patients: data from a multiethnic, multinational Latin American lupus cohort (GLADEL)
Cristina Reátegui-Sokolova, Manuel F Ugarte-Gil, Guillermina B Harvey, Daniel Wojdyla, Guillermo J Pons-Estel, Rosana Quintana, Rosa M Serrano-Morales, Mónica P Sacnun, Luis J Catoggio, Enrique R Soriano, Mercedes A García, Verónica Saurit, Alejandro Alvarellos, Francisco Caeiro, Guillermo A Berbotto, Emilia I Sato, Eduardo Ferreira Borba Neto, Eloisa Bonfa, Ana Carolina de Oliveira e Silva Montandon, Nilzio A Da Silva, Fernando Cavalcanti, Gloria Vásquez, Marlene Guibert-Toledano, Gil A Reyes-Llerena, Loreto Massardo, Oscar J Neira, Mario H Cardiel, Leonor A Barile-Fabris, Mary-Carmen Amigo, Luis H Silveira, Margarita Portela-Hernández, Ignacio Garcia de la Torre, María Inés Segami, Rosa Chacón-Diaz, María H Esteva-Spinetti, Graciela S Alarcón, Bernardo A Pons-Estel

RMD Open Dec 2020, 6 (3) e001299; DOI: 10.1136/rmdopen-2020-001299
Phase II, randomised, double-blind, multicentre study evaluating the safety and efficacy of filgotinib and lanraplenib in patients with lupus membranous nephropathy
Matthew Baker, Yashaar Chaichian, Mark Genovese, Vimal Derebail, Panduranga Rao, Winn Chatham, Michael Bubb, Sam Lim, Hooman Hajian, Oksana Gurtovaya, Uptal Patel, James Tumlin

RMD Open Dec 2020, 6 (3) e001490; DOI: 10.1136/rmdopen-2020-001490
Phase 3, long-term, open-label extension period of safety and efficacy of belimumab in patients with systemic lupus erythematosus in China, for up to 6 years
Fengchun Zhang, Jie Zheng, Yang Li, Guochun Wang, Mingjun Wang, Yin Su, Jieruo Gu, Xingfu Li, Damon Bass, Myron Chu, Paula Curtis, Kathleen DeRose, Regina Kurrasch, Jenny Lowe, Paige Meizlik, David A Roth

RMD Open Apr 2022, 8 (1) e001669; DOI: 10.1136/rmdopen-2021-001669

Main menu

Lupus Erythematosus

Pages

Log in using your username and password

Main menu

Log in using your username and password

You are here

Lupus Erythematosus

Pages